US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist

1.4600
+0.0600+4.29%

Trading Nov 22 14:04 ET

95.63MMarket Cap-1431P/E (TTM)

Regulus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-50.53%-9.45M

-86.13%-11.64M

-7.74%-8.74M

-4.87%-26.77M

2.05%-6.13M

6.77%-6.28M

-1.51%-6.25M

-27.16%-8.11M

-5.79%-25.53M

20.15%-6.25M

Net income from continuing operations

-79.73%-14.06M

-57.36%-11.04M

-18.63%-8.47M

-6.05%-30.04M

-18.63%-8.06M

-3.62%-7.82M

3.38%-7.01M

-6.25%-7.14M

-1.85%-28.32M

4.74%-6.8M

Depreciation and amortization

60.71%90K

89.36%89K

68.75%81K

86.07%227K

130.30%76K

75.00%56K

51.61%47K

84.62%48K

-73.42%122K

-19.51%33K

Other non cash items

--0

-80.00%10K

3.23%32K

6.02%141K

-12.50%28K

3.23%32K

56.25%50K

-18.42%31K

189.13%133K

357.14%32K

Change In working capital

401.68%2.69M

-758.16%-1.86M

-6.61%-1.5M

-53.27%257K

297.18%846K

25.76%537K

-55.66%282K

-93.94%-1.41M

-39.82%550K

115.03%213K

-Change in receivables

----

--0

----

-87.50%1K

50.00%-4K

----

-Change in prepaid assets

852.48%1.52M

-1,370.39%-1.93M

-33.48%445K

856.72%507K

87.11%-112K

-7.45%-202K

-50.81%152K

-1.76%669K

-180.72%-67K

13.53%-869K

-Change in payables and accrued expense

188.03%674K

1,174.39%881K

103.34%20K

-247.88%-698K

-170.97%-252K

-25.71%234K

-159.42%-82K

-633.93%-598K

258.92%472K

94.81%-93K

-Change in other current liabilities

36.14%-53K

-433.94%-1.46M

45.62%-149K

-1,290.00%-238K

-42.63%393K

-692.86%-83K

19.17%-274K

19.41%-274K

-72.60%20K

-14.59%685K

-Change in other working capital

-5.47%553K

35.46%657K

-51.29%-1.82M

448.80%686K

66.73%817K

104.55%585K

-6.73%485K

-2.56%-1.2M

-77.36%125K

-15.08%490K

Cash from discontinued investing activities

Operating cash flow

-50.53%-9.45M

-86.13%-11.64M

-7.74%-8.74M

-4.87%-26.77M

2.05%-6.13M

6.77%-6.28M

-1.51%-6.25M

-27.16%-8.11M

-5.79%-25.53M

20.15%-6.25M

Investing cash flow

Cash flow from continuing investing activities

442.72%18.64M

-83K

-623.66%-78.54M

195.84%14.49M

-52.88%4.93M

57.70%-5.44M

14,804.90%15M

-5,923.90%-15.12M

25,629.27%10.47M

Net PPE purchase and sale

94.82%-28K

---83K

-22,800.00%-229K

-68.98%-610K

-7.94%-68K

-17,933.33%-541K

--0

99.02%-1K

-43.82%-361K

-53.66%-63K

Net investment purchase and sale

481.14%18.67M

--0

-622.10%-78.32M

202.32%15.1M

-52.52%5M

61.90%-4.9M

--0

--15M

---14.76M

--10.53M

Cash from discontinued investing activities

Investing cash flow

442.72%18.64M

---83K

-623.66%-78.54M

195.84%14.49M

-52.88%4.93M

57.70%-5.44M

--0

14,804.90%15M

-5,923.90%-15.12M

25,629.27%10.47M

Financing cash flow

Cash flow from continuing financing activities

-80.49%56K

-105.63%-744K

11,665.84%93.11M

163.10%11.82M

-873K

-93.61%287K

13.21M

-40,350.00%-805K

-91.64%4.49M

Net issuance payments of debt

--0

33.29%-551K

0.00%-826K

---3.3M

---826K

--0

Net common stock issuance

-94.97%56K

-101.38%-194K

447,180.95%93.93M

236.67%15.12M

---47K

-75.21%1.11M

--14.03M

950.00%21K

-91.65%4.49M

--0

Proceeds from stock option exercised by employees

--0

--1K

--2K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

-80.49%56K

-105.63%-744K

11,665.84%93.11M

163.10%11.82M

---873K

-93.61%287K

--13.21M

-40,350.00%-805K

-91.64%4.49M

--0

Net cash flow

Beginning cash position

-53.96%17.18M

-2.38%29.65M

-1.90%23.83M

-59.81%24.29M

28.98%25.9M

6.09%37.33M

-43.72%30.37M

-59.81%24.29M

94.44%60.45M

-44.09%20.08M

Current changes in cash

180.94%9.25M

-279.21%-12.46M

-4.29%5.82M

98.72%-461K

-149.03%-2.07M

24.33%-11.43M

137.03%6.96M

193.81%6.08M

-223.15%-36.16M

-82.82%4.21M

End cash Position

2.09%26.44M

-53.96%17.18M

-2.38%29.65M

-1.90%23.83M

28.98%25.9M

6.09%37.33M

-43.72%30.37M

-59.81%24.29M

Free cash flow

-39.00%-9.48M

-87.46%-11.72M

-10.55%-8.97M

-5.77%-27.38M

1.90%-6.2M

-1.22%-6.82M

1.57%-6.25M

-25.17%-8.12M

-6.19%-25.89M

19.77%-6.32M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-50.53%-9.45M	-86.13%-11.64M	-7.74%-8.74M	-4.87%-26.77M	2.05%-6.13M	6.77%-6.28M	-1.51%-6.25M	-27.16%-8.11M	-5.79%-25.53M	20.15%-6.25M
Net income from continuing operations	-79.73%-14.06M	-57.36%-11.04M	-18.63%-8.47M	-6.05%-30.04M	-18.63%-8.06M	-3.62%-7.82M	3.38%-7.01M	-6.25%-7.14M	-1.85%-28.32M	4.74%-6.8M
Depreciation and amortization	60.71%90K	89.36%89K	68.75%81K	86.07%227K	130.30%76K	75.00%56K	51.61%47K	84.62%48K	-73.42%122K	-19.51%33K
Other non cash items	--0	-80.00%10K	3.23%32K	6.02%141K	-12.50%28K	3.23%32K	56.25%50K	-18.42%31K	189.13%133K	357.14%32K
Change In working capital	401.68%2.69M	-758.16%-1.86M	-6.61%-1.5M	-53.27%257K	297.18%846K	25.76%537K	-55.66%282K	-93.94%-1.41M	-39.82%550K	115.03%213K
-Change in receivables	----	--0	--0	----	----	----	-87.50%1K	50.00%-4K	----	----
-Change in prepaid assets	852.48%1.52M	-1,370.39%-1.93M	-33.48%445K	856.72%507K	87.11%-112K	-7.45%-202K	-50.81%152K	-1.76%669K	-180.72%-67K	13.53%-869K
-Change in payables and accrued expense	188.03%674K	1,174.39%881K	103.34%20K	-247.88%-698K	-170.97%-252K	-25.71%234K	-159.42%-82K	-633.93%-598K	258.92%472K	94.81%-93K
-Change in other current liabilities	36.14%-53K	-433.94%-1.46M	45.62%-149K	-1,290.00%-238K	-42.63%393K	-692.86%-83K	19.17%-274K	19.41%-274K	-72.60%20K	-14.59%685K
-Change in other working capital	-5.47%553K	35.46%657K	-51.29%-1.82M	448.80%686K	66.73%817K	104.55%585K	-6.73%485K	-2.56%-1.2M	-77.36%125K	-15.08%490K
Cash from discontinued investing activities
Operating cash flow	-50.53%-9.45M	-86.13%-11.64M	-7.74%-8.74M	-4.87%-26.77M	2.05%-6.13M	6.77%-6.28M	-1.51%-6.25M	-27.16%-8.11M	-5.79%-25.53M	20.15%-6.25M
Investing cash flow
Cash flow from continuing investing activities	442.72%18.64M	-83K	-623.66%-78.54M	195.84%14.49M	-52.88%4.93M	57.70%-5.44M	0	14,804.90%15M	-5,923.90%-15.12M	25,629.27%10.47M
Net PPE purchase and sale	94.82%-28K	---83K	-22,800.00%-229K	-68.98%-610K	-7.94%-68K	-17,933.33%-541K	--0	99.02%-1K	-43.82%-361K	-53.66%-63K
Net investment purchase and sale	481.14%18.67M	--0	-622.10%-78.32M	202.32%15.1M	-52.52%5M	61.90%-4.9M	--0	--15M	---14.76M	--10.53M
Cash from discontinued investing activities
Investing cash flow	442.72%18.64M	---83K	-623.66%-78.54M	195.84%14.49M	-52.88%4.93M	57.70%-5.44M	--0	14,804.90%15M	-5,923.90%-15.12M	25,629.27%10.47M
Financing cash flow
Cash flow from continuing financing activities	-80.49%56K	-105.63%-744K	11,665.84%93.11M	163.10%11.82M	-873K	-93.61%287K	13.21M	-40,350.00%-805K	-91.64%4.49M	0
Net issuance payments of debt	--0	33.29%-551K	0.00%-826K	---3.3M	---826K	---826K	---826K	---826K	--0	--0
Net common stock issuance	-94.97%56K	-101.38%-194K	447,180.95%93.93M	236.67%15.12M	---47K	-75.21%1.11M	--14.03M	950.00%21K	-91.65%4.49M	--0
Proceeds from stock option exercised by employees	--0	--1K	--2K	----	----	--0	--0	--0	----	----
Cash from discontinued financing activities
Financing cash flow	-80.49%56K	-105.63%-744K	11,665.84%93.11M	163.10%11.82M	---873K	-93.61%287K	--13.21M	-40,350.00%-805K	-91.64%4.49M	--0
Net cash flow
Beginning cash position	-53.96%17.18M	-2.38%29.65M	-1.90%23.83M	-59.81%24.29M	28.98%25.9M	6.09%37.33M	-43.72%30.37M	-59.81%24.29M	94.44%60.45M	-44.09%20.08M
Current changes in cash	180.94%9.25M	-279.21%-12.46M	-4.29%5.82M	98.72%-461K	-149.03%-2.07M	24.33%-11.43M	137.03%6.96M	193.81%6.08M	-223.15%-36.16M	-82.82%4.21M
End cash Position	2.09%26.44M	-53.96%17.18M	-2.38%29.65M	-1.90%23.83M	-1.90%23.83M	28.98%25.9M	6.09%37.33M	-43.72%30.37M	-59.81%24.29M	-59.81%24.29M
Free cash flow	-39.00%-9.48M	-87.46%-11.72M	-10.55%-8.97M	-5.77%-27.38M	1.90%-6.2M	-1.22%-6.82M	1.57%-6.25M	-25.17%-8.12M	-6.19%-25.89M	19.77%-6.32M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data